Why Onto Innovation ONTO earnings beat or miss matters less than you think Onto Innovation Misses Estimates as Demand Cools CBLL CeriBell Q4 loss narrows more than expected EPS surprise of 144 sends shares up 114 SILO Silo Pharma reports widerthanexpected Q4 2023 loss shares dip 162 amid weak investor sentiment PEG Public narrowly tops Q4 2025 EPS estimates shares rise on favorable investor sentiment Reinsurance RZC Q1 2026 Earnings Beat Revenue NA EPS 697 Fed Rate Hike Expectations Rise Traders Eye Possible Move by Mid2027 Trump Regrets Not Seeking Larger Intel Stake as Shares Surge Taseko Mines TGB Q1 2026 Disappoints EPS 008 Below 012 Views